Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

RecruitingOBSERVATIONAL
Enrollment

24,258

Participants

Timeline

Start Date

January 31, 1989

Primary Completion Date

January 31, 2099

Study Completion Date

January 31, 2099

Conditions
HIV InfectionsHepatitis B
Trial Locations (1)

28403

RECRUITING

Registry Coordinating Center, Wilmington

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

collaborator

Alvogen Inc.

UNKNOWN

collaborator

Amneal Pharmaceuticals, LLC

INDUSTRY

collaborator

Apotex Corp.

UNKNOWN

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Cipla Ltd.

INDUSTRY

collaborator

Dr. Reddy's Laboratories Limited

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Hetero Labs

UNKNOWN

collaborator

Hikma Pharmaceuticals LLC

INDUSTRY

collaborator

i3 Pharmaceuticals, LLC

UNKNOWN

collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

collaborator

Lannett Company, Inc.

INDUSTRY

collaborator

Laurus Labs Limited

UNKNOWN

collaborator

Lupin Pharmaceuticals, Inc.

INDUSTRY

collaborator

Macleods Pharmaceuticals Ltd

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Mylan Laboratories

INDUSTRY

collaborator

Pharmascience Inc.

INDUSTRY

collaborator

Qilu Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Sigmapharm Laboratories

UNKNOWN

collaborator

Strides Pharma Science Limited

UNKNOWN

collaborator

Teva Pharmaceuticals USA

INDUSTRY

collaborator

ViiV Healthcare

INDUSTRY

collaborator

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

collaborator

Zydus Pharmaceuticals USA, Inc.

INDUSTRY

lead

Syneos Health

OTHER